Alkermes stock jumps on positive ADHD drug trial results

disease outbreak active 81% Health

Alkermes stock jumped following positive results from ADHD drug trials, signaling potential market success and improved treatment options for patients. The development highlights pharmaceutical sector advancements.

🌐 Location: CY — Sources: 4 — First seen: — Last seen:
Alkermes stock jump ADHD drug trials pharmaceuticals

Linked Entities

Alkermes

organization responder

Quest Diagnostics

organization responder

Labcorp

organization responder

AnaptysBio

organization responder

Contributing Articles